Browsing Category

43957 posts
Aurzen Shines at IFA 2026, Garnering 11 Honors Across Its Projector Lineup

Aurzen Shines at IFA 2026, Garnering 11 Honors Across Its Projector Lineup

IRVINE, Calif., Sept. 8, 2026 /PRNewswire/ — Aurzen made a strong impression…
Reimagining finance: DIFC to convene global leaders across banking, private markets, asset management, FinTech, public policy and sustainability at Dubai Future Finance Week

Reimagining finance: DIFC to convene global leaders across banking, private markets, asset management, FinTech, public policy and sustainability at Dubai Future Finance Week

DUBAI, UAE, Sept. 8, 2026 /PRNewswire/ — Dubai International Financial Centre (DIFC),…

One Year In, Drunk Angel Defines Its Distinctive Approach to Crystal Jewelry

NEW YORK, Sept. 8, 2026 /PRNewswire/ — One year after establishing its…

ClubMed Lifestyle Group Advances Global Expansion Through Industry Collaboration and AI Application

HONG KONG, Sept. 8, 2026 /PRNewswire/ — ClubMed Lifestyle Group, a subsidiary…
As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen

As Global Heatwaves Intensify, Kolmar Korea Brings Cooling Innovation to Sunscreen

Kolmar Korea advances K-sun care with non-menthol cooling ingredients, water-drop technology, and…
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of .7 Billion

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.93 Million Tokens, and Total Crypto and Total Cash Holdings of $15.7 Billion

Bitmine owns 4.9% of the total ETH coin supply of 122.0 million…

Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo

NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ — Accro Bioscience…

HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the…